Related Experiment Videos
Bioavailability of digoxin-hydroquinone complex: a new oral digoxin formulation
Journal of Pharmaceutical Sciences
|May 1, 1977
Summary
A novel digoxin-hydroquinone complex demonstrated comparable bioavailability to digoxin elixir, with reduced interindividual variability. This new oral formulation achieved higher and faster peak serum digoxin levels compared to a standard digoxin tablet.
Area of Science:
- Pharmacology
- Drug Formulation
- Clinical Pharmacology
Background:
- Digoxin is a critical medication for heart failure and arrhythmias.
- Optimizing digoxin's oral bioavailability and absorption profile is essential for therapeutic efficacy.
- Existing digoxin formulations exhibit variable dissolution and absorption rates.
Purpose of the Study:
- To evaluate the bioavailability and pharmacokinetic profile of a new oral digoxin-hydroquinone complex.
- To compare this novel formulation against commercial digoxin tablets, elixir, and parenteral solutions.
- To assess the rate and extent of serum digoxin absorption and interindividual variability.
Main Methods:
- A comparative pharmacokinetic study involving 12 healthy volunteers.
- Administration of the digoxin-hydroquinone complex, digoxin tablet, digoxin elixir, and parenteral digoxin.
- Assessment of bioavailability via 24-hour serum digoxin-time curve (AUC) and 48-hour urinary excretion.
- Measurement of peak serum digoxin levels and time to reach peak concentration.
Main Results:
- The digoxin-hydroquinone complex exhibited rapid dissolution (99% at 5 min), significantly faster than the commercial tablet (26% at 5 min).
- Bioavailability of the complex was comparable to the elixir and not statistically different from the tablet, but the tablet showed lower bioavailability than the elixir.
- The novel complex demonstrated less interindividual variation in bioavailability compared to the elixir.
- Peak serum digoxin levels were higher and achieved more rapidly with the complex than with the tablet.
Conclusions:
- The digoxin-hydroquinone complex represents a promising new oral formulation with favorable pharmacokinetic properties.
- This formulation offers potential advantages in terms of faster absorption and reduced variability compared to existing oral digoxin products.
- Further clinical studies are warranted to confirm the therapeutic benefits of this advanced digoxin formulation.